AB-1005 Long-Term Follow-up Study

Part of paid clinical trials in San Francisco, California.

Sponsor
AskBio Inc
Study ID
NCT07081841
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Observation — OTHER
    This is an observational study in which safety laboratories and non-invasive routine clinical assessments are conducted to gauge long term safety and efficacy.

Study Details

This is an observational, long term, follow-up study for participants with Parkinson's disease (PD) or Multiple System Atrophy-Parkinsonian subtype (MSA-P) who participated in prior interventional studies with AB-1005. It is intended to better understand the long-term safety of AB-1005, how well tolerated it is and how long lasting the effects are.

Key Dates

Start date
Sep 4, 2025
Status verified
Sep 2025
Primary completion
Sep 30, 2037
Completion
Mar 30, 2038

Study Design

Enrollment
132 participants (estimated)

Arms

  • Arm: Participants with PD
  • Arm: Participants with MSA-P

Primary Outcome Measure

Long term safety and tolerability [ Time Frame: Up to 10 years post surgery ]

Locations (2)

FacilityCityStateZIPSite coordinators
University of California San FranciscoSan FranciscoCalifornia94143-
Ohio State UniversityColumbusOhio43210-

Find similar trials in San Francisco, CA

By condition
Parkinson's disease
By specialty
NeurologyBrain disorders
By research site
University of California San Francisco· San Francisco, CAOhio State University· Columbus, OH

Related Studies